Biostage, Inc. Common Stock
BSTG
BSTG was delisted on the 5th of October, 2017.
44 hedge funds and large institutions have $9.37M invested in Biostage, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 7 closing their positions.
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
2% more funds holding
Funds holding: 43 → 44 (+1)
9% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 11
62% less capital invested
Capital invested by funds: $24.8M → $9.37M (-$15.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
California Public Employees Retirement System
Sacramento,
California
|
+$149K |
| 2 |
WIC
Woodmont Investment Counsel
Nashville,
Tennessee
|
+$117K |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$86.6K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$64.9K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$56.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$489K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$451K |
| 3 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
-$344K |
| 4 |
Morgan Stanley
New York
|
-$332K |
| 5 |
6CM
683 Capital Management
New York
|
-$240K |
BSTG Hedge Fund Activity: Q4 2014 in Review
44 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q4 2014, worth a combined $9.37M — down 62% from $24.8M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BSTG positions and 7 closed out — a net gain of 2 holders — while 10 added to existing stakes and 11 trimmed.
The largest buyer was California Public Employees Retirement System, adding an estimated $149K. The largest seller was Royce & Associates, cutting an estimated $489K.
- 44 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q4 2014, up from 43 in Q3 2014.
- Funds reported $9.37M of Biostage, Inc. Common Stock stock for Q4 2014, down 62% quarter-over-quarter.
- 9 funds opened new Biostage, Inc. Common Stock positions in Q4 2014 and 7 closed out, a net change of +2 holders.
- The largest Biostage, Inc. Common Stock buyer in Q4 2014 was California Public Employees Retirement System, an estimated $149K added.
- The largest Biostage, Inc. Common Stock seller in Q4 2014 was Royce & Associates, an estimated $489K sold.
Based on aggregated 13F filings for Q4 2014.